• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Turning Point Brands Announces First Quarter 2026 Results

    5/7/26 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary
    Get the next $TPB alert in real time by email
    • Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up from 21% in Q1 2025.
    • Raising FY 2026 Modern Oral Sales guidance; Introducing FY 2026 EBITDA guidance.

    Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the first quarter ended March 31, 2026.

    Q1 2026 Financial Highlights

    (All results reflect comparisons to prior-year period)

    • Total Consolidated Net Sales increased 16.8% to $124.3 million
      • Stoker's segment Net Sales increased 48.1%
      • Zig-Zag segment Net Sales decreased 22.4%
    • Gross Profit increased 14.6% to $68.3 million
    • Net Income decreased 19.0% to $11.7 million
    • Adjusted EBITDA decreased 6.5% to $25.9 million (see Schedule A for a reconciliation to net income)
    • Diluted EPS of $0.60 and Adjusted Diluted EPS of $0.76 compared to $0.79 and $0.91 respectively, in the same period one year ago (see Schedule B for a reconciliation to Diluted EPS)

    "We delivered a strong first quarter, driven by continued momentum in Modern Oral and disciplined execution across the portfolio," said Graham Purdy, President and CEO. "We believe we are in the early stages of a generational shift in nicotine consumption, with significant opportunity ahead as the category continues to evolve. We are investing behind our brands, commercial capabilities, and consumer reach to position us to capture meaningful share in white pouch, including through initiatives such as our recently announced TKO partnership featuring UFC. At the same time, our legacy brands continue to generate strong cash flow, providing the foundation to fund our strategic priorities. We remain confident in our ability to scale our modern oral business and drive long-term value for shareholders."

    Stoker's Products Segment (70% of total net sales in the quarter)

    For the first quarter, Stoker's segment net sales increased 48.1% from the prior year to $87.6 million, driven by triple-digit growth in Modern Oral net sales.

    For the first quarter, Stoker's segment gross profit increased 39.1% from the prior year to $47.3 million. Gross profit as a percentage of net sales decreased to 54.0% for the three months ended March 31, 2026, from 57.5% of net sales for the three months ended March 31, 2025, primarily driven by margin contribution from modern oral products.

    Zig-Zag Products Segment (30% of total net sales in the quarter)

    For the first quarter, Zig-Zag segment net sales decreased 22.4% from the prior year to $36.7 million. The decrease in net sales was driven primarily by lower U.S. papers and wraps shipments.

    For the first quarter, Zig-Zag segment gross profit decreased 18.1% from the prior year to $20.9 million. Gross profit as a percentage of net sales increased to 57.1% for the three months ended March 31, 2026, from 54.1% for the three months ended March 31, 2025, driven primarily by product mix.

    Performance Measures in the First Quarter

    Investment in the first quarter focused on sales and marketing efforts to support distribution and brand building. In the first quarter consolidated selling, general and administrative ("SG&A") expenses increased 53.2% from the prior year to $55.8 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.

    As of March 31, 2026, ending cash was $192.4 million and net debt was $101.4 million. The Company ended the quarter with total liquidity of $265.0 million, comprised of $192.4 million in cash and $72.6 million of asset backed revolving credit facility capacity.

    2026 Outlook

    • Full year Modern Oral Gross Sales of $280-$300 million (from $220- $240 million)
    • Full year Modern Oral Net Sales of $210-$225 million (from $180- $190 million)
    • Full Year Adjusted EBITDA of $70-$90 million, inclusive of investment in Modern Oral sales, marketing, and trade promotions

    Earnings Conference Call

    As previously disclosed, a conference call with the investment community to review TPB's financial results has been scheduled for 8:30 a.m. Eastern on Thursday, May 7, 2026. Investment community participants should dial in 10 minutes ahead of time using the toll-free number (800) 715-9871 (international participants should call (646) 307-1963) and follow the audio prompts after typing in the event ID: 4128483. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.

    Non-GAAP Financial Measures

    In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss). A reconciliation of these non-GAAP financial measures accompanies this release. Also note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation.

    About Turning Point Brands, Inc.

    Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker's®, FRE®, and ALP®. TPB's products are available in more than 220,000 retail outlets in North America and on sites such as www.zigzag.com, www.frepouch.com, and www.alppouch.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws, including our outlook for 2026 with respect to Modern Oral Gross and Net Sales and Adjusted EBIDTA. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, those included in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

    This press release contains TPB's preliminary determinations and current expectations, and such information is inherently uncertain. The preliminary estimates provided herein have been prepared by, and are the responsibility of, management and are subject to completion of TPB's customary quarter-end closing and review procedures and third-party review. As a result, TPB's reported information in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 may differ from this information, and any such differences may be material. In addition, the information furnished above does not include all of the information regarding TPB's financial condition and results of operations for the quarter ending March 31, 2026 that may be important to readers. As a result, readers are cautioned not to place undue reliance on the information furnished in this press release and should view this information in the context of TPB's full first quarter 2026 results when such results are disclosed by TPB in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.

    Financial Statements Follow on Subsequent Pages

    Turning Point Brands, Inc.
    Consolidated Statements of Income
    (dollars in thousands except share data)
    (unaudited)

     

     

    Three Months Ended March 31,

     

     

     

    2026

     

     

    2025

     

    Net sales

     

    $

    124,278

     

     

    $

    106,436

     

    Cost of sales

     

     

    55,983

     

     

     

    46,826

     

    Gross profit

     

     

    68,295

     

     

     

    59,610

     

    Selling, general, and administrative expenses

     

     

    55,811

     

     

     

    36,421

     

    Operating income

     

     

    12,484

     

     

     

    23,189

     

    Other expense, net

     

     

    63

     

     

     

    -

     

    Interest expense, net

     

     

    4,423

     

     

     

    4,414

     

    Investment gain

     

     

    (151

    )

     

     

    (141

    )

    Income from equity method investment

     

     

    (2,983

    )

     

     

    (150

    )

    Loss on extinguishment of debt

     

     

    -

     

     

     

    1,235

     

    Income from continuing operations before income taxes

     

     

    11,132

     

     

     

    17,831

     

    Income tax (benefit) expense

     

     

    (2,810

    )

     

     

    2,040

     

    Consolidated net income

     

     

    13,942

     

     

     

    15,791

     

    Net income attributable to non-controlling interest

     

     

    2,275

     

     

     

    1,396

     

    Net income attributable to Turning Point Brands, Inc.

     

    $

    11,667

     

     

    $

    14,395

     

     

     

     

     

     

     

     

     

     

    Basic income per common share:

     

     

     

     

     

     

     

     

    Net income attributable to Turning Point Brands, Inc.

     

    $

    0.61

     

     

    $

    0.81

     

    Diluted income per common share:

     

     

     

     

     

     

     

     

    Net income attributable to Turning Point Brands, Inc.

     

    $

    0.60

     

     

    $

    0.79

     

    Weighted average common shares outstanding:

     

     

     

     

     

     

     

     

    Basic

     

     

    19,214,389

     

     

     

    17,795,243

     

    Diluted

     

     

    19,474,877

     

     

     

    18,249,306

     

    Turning Point Brands, Inc.

    Consolidated Balance Sheets

    (dollars in thousands except share data)

    (unaudited)

     

     

    March 31,

     

     

    December 31,

     

    ASSETS

     

    2026

     

     

    2025

     

    Current assets:

     

     

     

     

     

     

     

     

    Cash

     

    $

    192,439

     

     

    $

    222,760

     

    Accounts receivable, net of allowances of $228 in 2026 and $206 in 2025

     

     

    27,473

     

     

     

    25,726

     

    Inventories, net

     

     

    129,580

     

     

     

    107,989

     

    Other current assets

     

     

    68,712

     

     

     

    60,675

     

    Total current assets

     

     

    418,204

     

     

     

    417,150

     

    Property, plant, and equipment, net

     

     

    40,584

     

     

     

    36,247

     

    Right of use assets

     

     

    15,409

     

     

     

    14,480

     

    Deferred financing costs, net

     

     

    1,019

     

     

     

    1,180

     

    Goodwill

     

     

    135,974

     

     

     

    136,097

     

    Other intangible assets, net

     

     

    63,731

     

     

     

    64,042

     

    Master Settlement Agreement (MSA) escrow deposits

     

     

    29,786

     

     

     

    29,887

     

    Other assets

     

     

    67,390

     

     

     

    64,667

     

    Total assets

     

    $

    772,097

     

     

    $

    763,750

     

     

     

     

     

     

     

     

     

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

     

     

    Accounts payable

     

    $

    35,889

     

     

    $

    20,420

     

    Accrued liabilities

     

     

    35,394

     

     

     

    54,587

     

    Total current liabilities

     

     

    71,283

     

     

     

    75,007

     

    Deferred income tax liability

     

     

    8,363

     

     

     

    8,289

     

    Notes payable and long-term debt

     

     

    293,885

     

     

     

    293,625

     

    Other long-term liabilities

     

     

    2,034

     

     

     

    4,138

     

    Lease liabilities

     

     

    11,043

     

     

     

    10,708

     

    Total liabilities

     

     

    386,608

     

     

     

    391,767

     

     

     

     

     

     

     

     

     

     

    Stockholders' equity:

     

     

     

     

     

     

     

     

    Preferred stock, $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-

     

     

    -

     

     

     

    -

     

    Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,824,677 issued shares and 19,367,534 outstanding shares at March 31, 2026, and 20,589,527 issued shares and 19,132,384 outstanding shares at December 31, 2025

     

     

    218

     

     

     

    216

     

    Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-

     

     

    -

     

     

     

    -

     

    Additional paid-in capital

     

     

    205,542

     

     

     

    203,627

     

    Cost of repurchased common stock (1,457,143 shares at March 31, 2026 and 1,457,143 shares at December 31, 2025)

     

     

    (47,637

    )

     

     

    (47,637

    )

    Accumulated other comprehensive loss

     

     

    (2,090

    )

     

     

    (1,563

    )

    Accumulated earnings

     

     

    209,730

     

     

     

    199,661

     

    Non-controlling interest

     

     

    19,726

     

     

     

    17,679

     

    Total stockholders' equity

     

     

    385,489

     

     

     

    371,983

     

    Total liabilities and stockholders' equity

     

    $

    772,097

     

     

    $

    763,750

     

    Turning Point Brands, Inc.
    Consolidated Statements of Cash Flows
    (dollars in thousands)
    (unaudited)

     

     

    Three Months Ended March 31,

     

     

     

    2026

     

     

    2025

     

    Cash flows from operating activities:

     

     

     

     

     

     

     

     

    Consolidated net income

     

    $

    13,942

     

     

    $

    15,791

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

     

    Loss on extinguishment of debt

     

     

    -

     

     

     

    1,235

     

    Loss on sale of property, plant, and equipment

     

     

    -

     

     

     

    40

     

    Income from equity method investment

     

     

    (2,983

    )

     

     

    (150

    )

    Gain on investments

     

     

    (15

    )

     

     

    -

     

    Depreciation and other amortization expense

     

     

    1,753

     

     

     

    1,309

     

    Amortization of other intangible assets

     

     

    306

     

     

     

    307

     

    Amortization of deferred financing costs

     

     

    421

     

     

     

    448

     

    Deferred income tax expense

     

     

    96

     

     

     

    1,716

     

    Stock compensation expense

     

     

    2,938

     

     

     

    1,664

     

    Noncash lease income

     

     

    (807

    )

     

     

    (380

    )

    Changes in operating assets and liabilities:

     

     

     

     

     

     

     

     

    Accounts receivable

     

     

    (1,941

    )

     

     

    (5,539

    )

    Inventories

     

     

    (21,700

    )

     

     

    (8,310

    )

    Other current assets

     

     

    (8,062

    )

     

     

    (5,399

    )

    Other assets

     

     

    (108

    )

     

     

    (1,268

    )

    Accounts payable

     

     

    15,637

     

     

     

    15,433

     

    Accrued liabilities and other

     

     

    (21,736

    )

     

     

    512

     

    Net cash (used in) provided by operating activities

     

    $

    (22,259

    )

     

    $

    17,409

     

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

     

    Capital expenditures

     

    $

    (5,139

    )

     

    $

    (2,185

    )

    Payment for equity investments

     

     

    -

     

     

     

    (2,783

    )

    Purchases of investments

     

     

    (2,283

    )

     

     

    (714

    )

    Proceeds from sale of investments

     

     

    2,351

     

     

     

    500

     

    MSA escrow deposits, net

     

     

    5

     

     

     

    (48

    )

    Net cash used in investing activities

     

    $

    (5,066

    )

     

    $

    (5,230

    )

     

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

     

    Redemption of 2026 Notes

     

    $

    -

     

     

    $

    (250,000

    )

    Proceeds from 2032 Notes

     

     

    -

     

     

     

    300,000

     

    Payment of dividends

     

     

    (1,671

    )

     

     

    (1,385

    )

    Payments of financing costs

     

     

    -

     

     

     

    (6,582

    )

    Exercise of options

     

     

    323

     

     

     

    973

     

    Redemption of options

     

     

    -

     

     

     

    (33

    )

    Redemption of restricted stock units

     

     

    (330

    )

     

     

    (1,828

    )

    Redemption of performance based restricted stock units

     

     

    (1,014

    )

     

     

    (2,625

    )

    Net cash (used in) provided by financing activities

     

    $

    (2,692

    )

     

    $

    38,520

     

     

     

     

     

     

     

     

     

     

    Net (decrease) increase in cash

     

    $

    (30,017

    )

     

    $

    50,699

     

    Effect of foreign currency translation on cash

     

    $

    (304

    )

     

    $

    (48

    )

     

     

     

     

     

     

     

     

     

    Cash, beginning of period:

     

     

     

     

     

     

     

     

    Unrestricted

     

    $

    222,760

     

     

    $

    48,941

     

    Restricted

     

     

    1,914

     

     

     

    1,961

     

    Total cash at beginning of period

     

    $

    224,674

     

     

    $

    50,902

     

     

     

     

     

     

     

     

     

     

    Cash, end of period:

     

     

     

     

     

     

     

     

    Unrestricted

     

    $

    192,439

     

     

    $

    99,640

     

    Restricted

     

     

    1,914

     

     

     

    1,913

     

    Total cash at end of period

     

    $

    194,353

     

     

    $

    101,553

     

    Non-GAAP Financial Measures

    To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss). We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Adjusted Operating Income (Loss) are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

    We define "EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization. We define "Adjusted EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, income tax expense, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Net Income" as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Diluted EPS" as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Operating Income (Loss)" as operating income (loss) excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.

    Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA, Adjusted Diluted EPS, and Adjusted Operating Income (Loss) exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

    In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures. Note that a reconciliation of forward-looking non-GAAP measures, including EBITDA, to the most directly comparable GAAP measures is not provided because comparable GAAP measures for such measures are not reasonably accessible or reliable due to the inherent difficulty in forecasting and quantifying measures that would be necessary for such reconciliation.

    Schedule A

     

    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted EBITDA
    (dollars in thousands)
    (unaudited)

     

     

     

    Three Months Ended

     

     

     

    March 31,

     

     

     

    2026

     

     

    2025

     

    Net income attributable to Turning Point Brands, Inc.

     

    $

    11,667

     

     

    $

    14,395

     

    Add:

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    4,569

     

     

     

    4,401

     

    Loss on extinguishment of debt

     

     

    -

     

     

     

    1,235

     

    Income tax (benefit) expense

     

     

    (2,492

    )

     

     

    2,040

     

    Depreciation expense

     

     

    794

     

     

     

    828

     

    Amortization expense

     

     

    1,285

     

     

     

    822

     

    EBITDA

     

    $

    15,823

     

     

    $

    23,721

     

    Components of Adjusted EBITDA

     

     

     

     

     

     

     

     

    Corporate restructuring (a)

     

     

    97

     

     

     

    -

     

    ERP/CRM (b)

     

     

    -

     

     

     

    211

     

    Stock based compensation (c)

     

     

    2,938

     

     

     

    1,664

     

    Transactional expenses and strategic initiatives (d)

     

     

    145

     

     

     

    176

     

    Non-recurring legal (e)

     

     

    153

     

     

     

    -

     

    FDA PMTA (f)

     

     

    290

     

     

     

    1,591

     

    Mark-to-market gain on Canadian inter-company note (g)

     

     

    (116

    )

     

     

    315

     

    Tariff adjustment (h)

     

     

    5,903

     

     

     

    -

     

    Manufacturing start-up costs (i)

     

     

    594

     

     

     

    -

     

    Honorarium (j)

     

     

    63

     

     

     

    -

     

    Adjusted EBITDA

     

    $

    25,890

     

     

    $

    27,678

     

     

    (a)

    Represents costs associated with corporate restructuring, including severance and early retirement.

    (b)

    Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.

    (c)

    Represents non-cash stock options, restricted stock, PSRUs, etc.

    (d)

    Represents the fees incurred for transaction expenses.

    (e)

    Represents legal expenses incurred in connection with litigation related to an insurance claim.

    (f)

    Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete.

    (g)

    Represents a mark-to-market loss attributable to foreign exchange fluctuation.

    (h)

    Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund.

    (i)

    Represents non-recurring expenses incurred during the start-up of manufacturing lines.

    (j)

    Represents an honorarium gift included in other expense, net.

    Schedule B

     

    Turning Point Brands
    Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
    (dollars in thousands except share data)
    (unaudited)

     

     

    Three Months Ended

     

     

    Three Months Ended

     

     

     

    March 31, 2026

     

     

    March 31, 2025

     

     

     

    Income from continuing

    operations

    before income

    taxes

     

     

    Income tax

    expense (m)

     

     

    Net loss

    attributable to

    non-

    controlling

    interest

     

     

    Adjusted Net

    Income

     

     

    Adjusted

    Diluted EPS

     

     

    Income from continuing

    operations

    before income

    taxes

     

     

    Income tax

    expense (m)

     

     

    Net loss

    attributable to

    non-

    controlling

    interest

     

     

    Net Income

     

     

    Diluted EPS

     

    GAAP Net Income and Diluted EPS

     

    $

    11,132

     

     

    $

    (2,810

    )

     

    $

    2,275

     

     

    $

    11,667

     

     

    $

    0.60

     

     

    $

    17,831

     

     

    $

    2,040

     

     

    $

    1,396

     

     

    $

    14,395

     

     

    $

    0.79

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Loss on extinguishment of debt (a)

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    1,235

     

     

     

    141

     

     

     

    -

     

     

     

    1,094

     

     

     

    0.06

     

    Corporate restructuring (b)

     

     

    97

     

     

     

    (24

    )

     

     

    -

     

     

     

    121

     

     

     

    0.01

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

    ERP/CRM (c)

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    211

     

     

     

    24

     

     

     

    -

     

     

     

    187

     

     

     

    0.01

     

    Stock based compensation (d)

     

     

    2,938

     

     

     

    (742

    )

     

     

    -

     

     

     

    3,680

     

     

     

    0.19

     

     

     

    1,664

     

     

     

    190

     

     

     

    -

     

     

     

    1,474

     

     

     

    0.08

     

    Transactional expenses and strategic initiatives(e)

     

     

    145

     

     

     

    (37

    )

     

     

    -

     

     

     

    182

     

     

     

    0.01

     

     

     

    176

     

     

     

    20

     

     

     

    -

     

     

     

    156

     

     

     

    0.01

     

    Non-recurring legal (f)

     

     

    153

     

     

     

    (39

    )

     

     

    -

     

     

     

    192

     

     

     

    0.01

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

    FDA PMTA (g)

     

     

    290

     

     

     

    (73

    )

     

     

    -

     

     

     

    363

     

     

     

    0.02

     

     

     

    1,591

     

     

     

    182

     

     

     

    -

     

     

     

    1,409

     

     

     

    0.08

     

    Mark-to-market loss on Canadian inter-company note (h)

     

     

    (116

    )

     

     

    29

     

     

     

    -

     

     

     

    (145

    )

     

     

    (0.01

    )

     

     

    315

     

     

     

    36

     

     

     

    -

     

     

     

    279

     

     

     

    0.02

     

    Tariff adjustment (i)

     

     

    5,903

     

     

     

    (1,490

    )

     

     

    -

     

     

     

    7,393

     

     

     

    0.38

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

    Manufacturing start-up costs (j)

     

     

    594

     

     

     

    (150

    )

     

     

    -

     

     

     

    744

     

     

     

    0.04

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

    Honorarium (k)

     

     

    63

     

     

     

    (16

    )

     

     

    -

     

     

     

    79

     

     

     

    0.00

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

     

     

    -

     

    Tax benefit (l)

     

     

    -

     

     

     

    9,475

     

     

     

    -

     

     

     

    (9,475

    )

     

     

    (0.49

    )

     

     

    -

     

     

     

    2,329

     

     

     

    -

     

     

     

    (2,329

    )

     

     

    (0.13

    )

    Adjusted Net Income and Adjusted Diluted EPS

     

    $

    21,199

     

     

    $

    4,124

     

     

    $

    2,275

     

     

    $

    14,800

     

     

    $

    0.76

     

     

    $

    23,023

     

     

    $

    4,963

     

     

    $

    1,396

     

     

    $

    16,664

     

     

    $

    0.91

     

     

    (a)

    Represents loss on extinguishment of debt as a result of the redemptions of the 2026 Notes.

    (b)

    Represents costs associated with corporate restructuring, including severance and early retirement.

    (c)

    Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.

    (d)

    Represents non-cash stock options, restricted stock, PSRUs, etc.

    (e)

    Represents the fees incurred for transaction expenses.

    (f)

    Represents legal expenses incurred in connection with litigation related to an insurance claim.

    (g)

    Represents costs associated with applications related to FDA premarket tobacco production application ("PMTA").The PMTA regime requires the Company to submit an application to the FDA to receive marketing authorization to continue to sell certain of its product lines with continued sales permitted during the pendency of the applications. The application is a one-time resource-intensive process for each covered product line; however, due to the nature of the implementation process for those product lines already in the market, applications can take multiple years to complete rather than the typical one-time submission. The Company currently has only two product lines currently subject to the PMTA process, having utilized other regulatory pathway options available for our other product lines. The Company does not expect to submit additional PMTA applications for any new product lines after the submission for the pending two are complete.

    (h)

    Represents a mark-to-market loss attributable to foreign exchange fluctuation.

    (i)

    Represents adjustment to current period costs of goods sold to exclude tariffs subject to refund.

    (j)

    Represents non-recurring expenses incurred during the start-up of manufacturing lines.

    (k)

    Represents an honorarium gift included in other expense, net.

    (l)

    Represents adjustment from quarterly tax rate to quarterly projected tax rate of 24% in 2026 and 21% in 2025.

    (m)

    Income tax expense calculated using the effective tax rate for the quarter of -25.2% in 2026 and 11.4% in 2025.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260507230137/en/

    Investor Contacts

    Turning Point Brands, Inc.

    ir@tpbi.com

    Get the next $TPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TPB

    DatePrice TargetRatingAnalyst
    5/8/2026$125.00Hold → Buy
    Needham
    8/1/2025Hold
    Needham
    3/3/2025$80.00Buy
    Alliance Global Partners
    11/14/2024$65.00Outperform
    Oppenheimer
    9/19/2024$50.00Buy
    ROTH MKM
    6/6/2023$28.00Buy
    The Benchmark Company
    10/10/2022$28.00 → $22.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $TPB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares (4,000 units at $31.80), increasing direct ownership by 13% to 34,896 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/24 5:01:10 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Chief Revenue Officer Frein Summer bought $69,970 worth of shares (2,260 units at $30.96), increasing direct ownership by 15% to 17,203 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/14/24 6:50:56 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    De Plano Lorenzo bought $420,753 worth of shares (15,043 units at $27.97), increasing direct ownership by 92% to 31,375 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/18/24 9:17:02 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ALP Signs Conor McGregor as Global Brand Partner in Landmark Deal

    Partnership Marks Major Growth Milestone for One of the Fastest-Rising Nicotine Pouch Brands in the IndustryMIAMI, May 20, 2026 /PRNewswire/ -- ALP, one of the fastest-growing nicotine pouch brands in the market, today announced a landmark partnership with global combat sports icon Conor McGregor, officially welcoming the UFC champion to the ALP family. The announcement comes at a pivotal moment for both the brand and McGregor, as anticipation builds around his highly anticipated return during International Fight Week in July.Founded less than two years ago, ALP has rapidly emer

    5/20/26 10:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Announces First Quarter 2026 Results

    Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up from 21% in Q1 2025. Raising FY 2026 Modern Oral Sales guidance; Introducing FY 2026 EBITDA guidance. Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial Highlights (All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 16.8% to $124.3 million Stoker's segment Net Sales

    5/7/26 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Declares Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. The dividend is payable on July 10, 2026 to shareholders of record on the close of business on June 19, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker's®, F

    5/4/26 5:20:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Turning Point Brands upgraded by Needham with a new price target

    Needham upgraded Turning Point Brands from Hold to Buy and set a new price target of $125.00

    5/8/26 8:30:07 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Needham initiated coverage on Turning Point Brands

    Needham initiated coverage of Turning Point Brands with a rating of Hold

    8/1/25 8:13:43 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Alliance Global Partners initiated coverage on Turning Point Brands with a new price target

    Alliance Global Partners initiated coverage of Turning Point Brands with a rating of Buy and set a new price target of $80.00

    3/3/25 8:28:08 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    SEC Filings

    View All

    SEC Form 10-Q filed by Turning Point Brands Inc.

    10-Q - Turning Point Brands, Inc. (0001290677) (Filer)

    5/8/26 4:16:58 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Turning Point Brands, Inc. (0001290677) (Filer)

    5/7/26 8:10:40 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Turning Point Brands, Inc. (0001290677) (Filer)

    5/5/26 5:28:22 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Reddy Rohith was granted 1,295 shares, increasing direct ownership by 24% to 6,795 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    5/13/26 8:44:43 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Sr VP Finance & CAO Wigginton Brian sold $366,680 worth of shares (4,000 units at $91.67), decreasing direct ownership by 30% to 9,230 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    5/13/26 8:43:28 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Director Wexler Lawrence was granted 1,295 shares, increasing direct ownership by 0.45% to 287,689 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    5/13/26 8:42:23 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Leadership Updates

    Live Leadership Updates

    View All

    Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer

    Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today the appointment Andrew Flynn as the Company's new Chief Financial Officer, effective on or before April 1, 2024. Mr. Flynn is replacing Louie Reformina, who will step down to pursue other opportunities. Prior to joining Turning Point Brands, Mr. Flynn served as the CFO of Connected Cannabis Co. where he was responsible for bringing sustained profitable growth, expanding geographically and recapitalizing the company. In this role Mr. Flynn operationalized and

    3/11/24 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

    GRANT-VALKARIA, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we"), today announced that it has appointed James W. Dobbins as General Counsel effective December 5, 2023. Barry Hopkins, Executive Chairman of Kaival Brands, said, "James Dobbins has extensive experience advising companies on a breadth of legal matters, and importantly, he also has a deep, relevant understanding of industry business operations, including corporate governance, M&A, international sourcing, and compliance matters. Along with an anticipated reduction in legal expenses, we are thrilled to welcome James to guide and assist our execut

    12/7/23 8:30:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    Kaival Brands Appoints New Chief Executive Officer and Chief Financial Officer

    Former Turning Points Brands executive Thomas Metzler brings decades of finance and operational industry experience to Kaival Brands as its new Chief Financial Officer Current President & Chief Operating Officer Eric Mosser promoted to Chief Executive Officer GRANT-VALKARIA, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company" or "we," "our" or similar terms), a company focused on incubating and commercializing innovative products into mature and dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (ENDS), which are intended for adults 21 and over, today announced the appoi

    8/3/23 8:15:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    $TPB
    Financials

    Live finance-specific insights

    View All

    Turning Point Brands Announces First Quarter 2026 Results

    Q1 2026 Modern Oral Net Sales increased 133% to $52.0 million, accounting for 42% of total company net sales, up from 21% in Q1 2025. Raising FY 2026 Modern Oral Sales guidance; Introducing FY 2026 EBITDA guidance. Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial Highlights (All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 16.8% to $124.3 million Stoker's segment Net Sales

    5/7/26 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Declares Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. The dividend is payable on July 10, 2026 to shareholders of record on the close of business on June 19, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic brand portfolio, including Zig-Zag®, Stoker's®, F

    5/4/26 5:20:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands to Host Q1 2026 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review first quarter 2026 results. The conference call will be on Thursday, May 7, 2026 at 8:30 a.m. Eastern Time. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 4128483 Participants should dial in at least ten minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/investor-r

    4/27/26 5:42:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/14/24 12:37:11 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 4:32:30 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 12:58:51 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Turning Point Brands Inc. on Jun 18 Indicate?

    On June 18, 2024, Turning Point Brands Inc. experienced a significant insider purchase when Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares. This transaction involved the acquisition of 4,000 units at a price of $31.80 per unit, leading to an increase in his direct ownership by 13% to 34,896 units, as reported in the SEC Form 4. This move by an insider to increase their stake in the company is generally viewed as a positive signal by the market. Examining the recent insider activity at Turning Point Brands Inc., we can identify a few notable trades that occurred around the same time. On May 10, 2024, New insider Catsimatidis John A. Jr claimed ownership of 410,000 sh

    6/18/24 10:08:05 PM ET
    $TPB
    Tobacco
    Consumer Discretionary